In this webinar, Dr. Anna Blakney from the University of British Columbia will discuss the development of next-generation saRNA technologies for vaccines and therapeutics. Her research focuses on engineering new RNA designs and optimizing nanoparticle delivery systems to improve the performance of saRNA.
RNA medicines, including mRNA vaccines, have transformed how we prevent and treat disease, but challenges remain in improving their effectiveness, durability, and safety. Self-amplifying RNA (saRNA) offers a promising approach by enabling longer-lasting therapeutic effects at much lower doses.
In this webinar, Dr. Anna Blakney from the University of British Columbia will discuss the development of next-generation saRNA technologies for vaccines and therapeutics. Her research focuses on engineering new RNA designs and optimizing nanoparticle delivery systems to improve the performance of saRNA.
The webinar will explore how molecular and biomaterial engineering strategies can enhance RNA expression, delivery, and therapeutic potential. These advances may support the development of more effective vaccines and therapies for infectious diseases, cancer, genetic disorders, and other applications.
Key Topics
- Engineering self-amplifying RNA for improved therapeutic performance
- Optimizing nanoparticle systems for efficient saRNA delivery
- Improving the effectiveness and durability of RNA-based therapies
- Applications of saRNA in vaccines and therapeutic development